Scholarlink

Purpose <p>As cancer incidence increases, internal medicine (IM) physicians play a growing role in managing the complex medical needs of cancer patients and survivors across the care continuum. However, few residency programs offer structured training in supportive oncology care. We developed a combined Baylor College of Medicine (BCM) and The University of Texas MD Anderson Cancer Center (MDACC) Onco-Medicine Track to equip IM residents with skills in cancer prevention, survivorship, symptom management, and interdisciplinary care.</p> Methods <p>This 3-year residency track launched in 2015 through a partnership between BCM and MDACC. Residents complete approximately one-third of their training in cancer-focused IM rotations, including onco-hospital medicine, palliative care, supportive care, and subspecialty experiences. Program development was informed by a feasibility assessment and modeled in part on career pathways at the University of California, San Francisco.</p> Results <p>As of 2024, the program has trained 35 graduates, 57% of whom pursued oncology-related careers. Board pass rates and in-training exam scores for track residents were comparable to peers. Resident evaluations emphasized the educational value of rotations focused on cancer screening, managing treatment-related complications, and improving communication skills as well as survivorship-focused competencies. Graduates have received national recognition through awards, presentations, and leadership roles. Demand remains strong, with consistent NRMP match fills and high applicant volumes.</p> Conclusions <p>The BCM–MDACC Onco-Medicine Track demonstrates a sustainable and scalable model for preparing internists in supportive cancer care and survivorship. Its integrated structure may inform similar efforts at other institutions, even those without access to a comprehensive cancer center.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

BCM-MD Anderson onco-medicine track: a novel internal medicine residency pathway to strengthen the supportive cancer care workforce

  • 期刊论文

  • 发表日期：

    2025年12月18日

查看全文
  • Ellen F. Manzullo,
  • Saadia A. Faiz,
  • Richard J. Hamill,
  • David J. Tweardy,
  • Charity A. Sembera,
  • Amit Lahoti,
  • Orhue Odaro

摘要

Purpose

As cancer incidence increases, internal medicine (IM) physicians play a growing role in managing the complex medical needs of cancer patients and survivors across the care continuum. However, few residency programs offer structured training in supportive oncology care. We developed a combined Baylor College of Medicine (BCM) and The University of Texas MD Anderson Cancer Center (MDACC) Onco-Medicine Track to equip IM residents with skills in cancer prevention, survivorship, symptom management, and interdisciplinary care.

Methods

This 3-year residency track launched in 2015 through a partnership between BCM and MDACC. Residents complete approximately one-third of their training in cancer-focused IM rotations, including onco-hospital medicine, palliative care, supportive care, and subspecialty experiences. Program development was informed by a feasibility assessment and modeled in part on career pathways at the University of California, San Francisco.

Results

As of 2024, the program has trained 35 graduates, 57% of whom pursued oncology-related careers. Board pass rates and in-training exam scores for track residents were comparable to peers. Resident evaluations emphasized the educational value of rotations focused on cancer screening, managing treatment-related complications, and improving communication skills as well as survivorship-focused competencies. Graduates have received national recognition through awards, presentations, and leadership roles. Demand remains strong, with consistent NRMP match fills and high applicant volumes.

Conclusions

The BCM–MDACC Onco-Medicine Track demonstrates a sustainable and scalable model for preparing internists in supportive cancer care and survivorship. Its integrated structure may inform similar efforts at other institutions, even those without access to a comprehensive cancer center.